According to research done by Leafreport, over half of CBG products contained a different percentage of the cannabinoid than stated. Of a total of 38 products tested in a cannabis testing lab, 48% was highly accurate (within 10% of what was stated), whereas the remaining 52% contained either more or less CBG than the label said it did.
"Out of 38 tested products, 18 (47.4%) got an A, 13 (34.2%) got a B, 5 (13.1%) got a C, and 2 (5.3%) received an F. In other words, over half (52.6%) had inaccurate CBG levels. However, all 15 products advertised to contain broad or full-spectrum CBD were correct. That’s a great result, since our previous reports found at least a few products that carried the wrong type of CBD extract," the Leafreport researchers shared.
"We also discovered that, out of 24 products advertised to contain both CBG and CBG, only 4 (17%) were accurate for both. Seven products (29%) were accurate for CBG but not CBD, 8 (33%) were accurate for CBD but not CBG, and 5 (21%) were inaccurate for both. These results suggest that it’s harder for brands to meet label claims for two rather than only one cannabinoid."
If you are interested in reading the whole research report, you can click here.